Gracey Craig 4

What Happened

• Gracey Craig, Chief Accounting Officer of Omada Health (OMDA), exercised stock option rights for a total of 1,042 shares (405 on 2026-06-30 and 637 on 2026-07-01) at an exercise price of $6.57 per share, and subsequently sold those shares in open-market transactions (sold 405 at $22.00 and 637 at $23.00). Gross sale proceeds were $23,561; the exercise cost was $6,846, for estimated proceeds before taxes/fees of about $16,715. The filing also reports the related derivative items at $0, which reflect conversion/disposition of the option instruments upon exercise.

Key Details

• Transaction dates and prices:
  • 2026-06-30: exercised 405 shares @ $6.57 (acquired $2,661) and sold 405 shares @ $22.00 (disposed $8,910).
  • 2026-07-01: exercised 637 shares @ $6.57 (acquired $4,185) and sold 637 shares @ $23.00 (disposed $14,651).
  • Additional Form-4 lines show the option derivatives being converted/disposed at $0 upon exercise.
• Total: 1,042 options exercised; total sales ≈ $23,561; total exercise cost ≈ $6,846.
• Shares owned after transaction: not specified in the supplied filing details.
• Footnotes: transactions were made pursuant to a 10b5‑1 trading plan adopted March 13, 2026 (F1). Vesting schedule for the option award: 25% after one year from Sept 9, 2024, then monthly vesting over 48 months (F2).
• Filing timeliness: no late filing is indicated in the provided information.

Context

• This was an option exercise followed by immediate open‑market sales of the resulting shares (i.e., the insider exercised vested options and sold the shares). Such exercises with same‑day or near‑term sales are commonly used to monetize vested equity; the presence of a 10b5‑1 plan indicates the trades were pre‑arranged to avoid concerns about trading on material nonpublic information. The filing does not provide the insider’s remaining ownership stake.